CAS: 1197420-05-5

BMS-819881 is a melaninconcentrating hormone receptor 1 (MCHR1) antagonist, which binds rat MCHR1 with a Ki of 7 nM and it also is selective and potent for

BMS 819881 is a synthetic chemical compound, classified as a pharmaceutical agent. This compound originates from synthetic processes in medicinal chemistry, developed as part of a structured drug discovery program. Its mode of action involves inhibiting specific molecular targets related to metabolic pathways, which are impactful in regulating physiological processes at the cellular level. The primary applications of BMS 819881 are in the domain of metabolic research and therapeutic development. It is extensively used in preclinical studies to elucidate disease mechanisms and assess potential therapeutic benefits. Additionally, BMS 819881's unique action on specific pathways makes it a candidate for exploring treatments for diseases where these pathways are dysregulated. Its effectiveness and specificity also make it a valuable tool for scientists aiming to understand complex biochemical networks and design subsequent interventions.